New Launch15 Nov 2024, 01:22 pm
Mankind Pharma Pledges 39.68% Equity Shares of Bharat Serums and Vaccines Limited for INR 5,000 Crores NCDs
AI Summary
Mankind Pharma Ltd. has pledged 39.68% equity shares of its wholly owned subsidiary, Bharat Serums and Vaccines Limited, in favor of Catalyst Trusteeship Limited as the Common Security Trustee for the benefit of holders of non-convertible debentures (NCDs) worth INR 5,000 crores. This decision was made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The equity shares will remain pledged until the settlement of NCDs.
Key Highlights
- Mankind Pharma pledges 39.68% equity shares of Bharat Serums and Vaccines Limited
- Pledged in favor of Catalyst Trusteeship Limited as the Common Security Trustee
- For the benefit of holders of non-convertible debentures (NCDs) worth INR 5,000 crores
- Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Equity shares will remain pledged until the settlement of NCDs